The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery
Status:
Terminated
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This trial will study the effects of fenoldopam on renal function in patients who have a
single kidney undergoing surgery to remove part of that kidney secondary to renal cell
carcinoma. The investigators will monitor and evaluate throughout the perioperative course
the kidney function. Normally kidney function is predicted to show a worsening followed by an
improvement after surgery.
The investigators want to specifically identify if the use of fenoldopam lessens the injury
to the kidney with this surgery.